Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Kulakowski

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|September 15, 1984
Hypoglycemic properties of taurine: not mediated by enhanced insulin releaseE C Kulakowski, J Maturo
Biochemical Pharmacology|October 1, 1988
Taurine binding to the purified insulin receptorJ Maturo, E C Kulakowski
Life Sciences|October 20, 1986
Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 AJ H Hurst, E C Kulakowski
Biochemical Pharmacology|March 15, 1983
Action of substance P on the working rat heartE C Kulakowski, W G Lampson, S W Schaffer, et al.
Journal of Hypertension|February 1, 1985
Enhanced sympathetic-adrenal medullary response to cold exposure in spontaneously hypertensive ratsY Yamori, K Ikeda, E C Kulakowski, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
The hypotensive action of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in spontaneously hypertensive ratsE C Kulakowski, J H Hurst, M Scheinin, et al.
Biochimica Et Biophysica Acta|February 20, 1979
Taurine enhancement of calcium binding to rat heart sarcolemmaJ P Chovan, E C Kulakowski, B W Benson, et al.
Life Sciences|September 17, 1984
The hypothermic effect of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in Wistar Kyoto ratsE C Kulakowski, J H Hurst, T Miller, et al.
Life Sciences|September 14, 1987
Naloxone reverses the serotonin dependent hypotensive action of CGP 6085 AD J Goldstein, E C Kulakowski, T G Ropchak, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|September 15, 1984
Hypoglycemic properties of taurine: not mediated by enhanced insulin releaseE C Kulakowski, J Maturo
Biochemical Pharmacology|October 1, 1988
Taurine binding to the purified insulin receptorJ Maturo, E C Kulakowski
Life Sciences|October 20, 1986
Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 AJ H Hurst, E C Kulakowski
Biochemical Pharmacology|March 15, 1983
Action of substance P on the working rat heartE C Kulakowski, W G Lampson, S W Schaffer, et al.
Journal of Hypertension|February 1, 1985
Enhanced sympathetic-adrenal medullary response to cold exposure in spontaneously hypertensive ratsY Yamori, K Ikeda, E C Kulakowski, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
The hypotensive action of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in spontaneously hypertensive ratsE C Kulakowski, J H Hurst, M Scheinin, et al.
Biochimica Et Biophysica Acta|February 20, 1979
Taurine enhancement of calcium binding to rat heart sarcolemmaJ P Chovan, E C Kulakowski, B W Benson, et al.
Life Sciences|September 17, 1984
The hypothermic effect of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in Wistar Kyoto ratsE C Kulakowski, J H Hurst, T Miller, et al.
Life Sciences|September 14, 1987
Naloxone reverses the serotonin dependent hypotensive action of CGP 6085 AD J Goldstein, E C Kulakowski, T G Ropchak, et al.
Pageof 1